{
    "Trade/Device Name(s)": [
        "chromID MRSA",
        "chromID MRSA agar",
        "chromID\u2122 MRSA agar"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K162076",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092407"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JSO"
    ],
    "Summary Letter Date": "October 25, 2016",
    "Summary Letter Received Date": "July 29, 2016",
    "Submission Date": "July 26, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.1700"
    ],
    "Regulation Name(s)": [
        "Culture medium for antimicrobial susceptibility tests"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA)"
    ],
    "Specimen Type(s)": [
        "Anterior nares swab",
        "Skin and skin structure specimens",
        "Positive blood culture"
    ],
    "Specimen Container(s)": [
        "Blood culture bottles",
        "Swab"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromogenic medium",
        "Manual culture"
    ],
    "Methodologies": [
        "Selective and differential chromogenic agar culture"
    ],
    "Submission Type(s)": [
        "Culture medium",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for chromID MRSA agar, a selective and differential chromogenic medium to detect MRSA in nasal swabs, skin/structure samples, and positive blood cultures.",
    "Indications for Use Summary": "Qualitative detection of MRSA to aid in prevention and control of MRSA in healthcare settings via anterior nares swabs, skin/skin structure specimens, and positive blood cultures; not intended for diagnosis, therapy guidance, or susceptibility determination.",
    "fda_folder": "Microbiology"
}